Search results for "Heart Valve Prosthesi"

showing 10 items of 66 documents

Numerical simulation of transcatheter mitral valve replacement: The dynamic implication of LVOT obstruction in the valve-in-ring case.

2022

Transcatheter mitral valve replacement (TMVR) has been used for “off-label” treatment when annuloplasty band ring for mitral repair fails. However, the complex anatomy and function of the mitral valve may lead to fatal complications as a result of the left ventricular outflow tract (LVOT) obstruction in TMVR. We report the structural and hemodynamic response of LVOT obstruction resulting from TMVR with the Edwards SAPIEN 3 Ultra (S3) device. We modified the original Living Heart Human Model (LHHM) to account for a failed mitral valve with an annuloplasty band ring and simulated the cardiac beating condition in the setting of S3 device implantation. Findings demonstrated a high dynamic behav…

Heart Valve Prosthesis ImplantationHeart Defects CongenitalHistoryCardiac CatheterizationPolymers and PlasticsRehabilitationBiomedical EngineeringBiophysicsMitral Valve InsufficiencyFinite Element (FE) analysisIndustrial and Manufacturing EngineeringVentricular Outflow ObstructionTreatment OutcomeRisk FactorsComputational Fluid Dynamic (CFD)Living heart human modelHeart Valve ProsthesisHumansMitral ValveOrthopedics and Sports MedicineBusiness and International ManagementTranscatheter mitral valve replacementJournal of biomechanics
researchProduct

Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology

2021

Mitral regurgitation (MR) is common in patients with heart failure and constitutes an independent risk factor for adverse prognosis besides NYHA-class. The predictive value of dyspnea reduction after transcatheter mitral valve repair (TMVr) on outcome has not been investigated up to now.We enrolled 627 consecutive patients (47.0% female, 57.4% functional MR; median follow-up 486 days[IQR 157/961]; survival status available in 96.8%; symptoms assessed in n = 556 at baseline / n = 406 at 1 month) treated with isolated percutaneous mitral valve edge-to-edge repair in our center from 06/2010-03/2018 (exclusion of combined forms of TMVr) in a monocentric retrospective analysis. Survival was 97.6…

Heart Valve Prosthesis ImplantationMaleMitral valve repairmedicine.medical_specialtyMitral regurgitationEjection fractionbusiness.industrymedicine.medical_treatmentMitraClipPrognosismedicine.diseaseSymptomatic reliefSurgeryTreatment Outcomemedicine.anatomical_structureInterquartile rangeHeart failureMitral valvemedicineHumansMitral ValveFemaleCardiology and Cardiovascular MedicinebusinessRetrospective StudiesInternational Journal of Cardiology
researchProduct

Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement

2016

Background and aim of the study: The study aim was to determine the impact of prosthesis-patient mismatch (PPM) on early and late clinical outcomes, left atrial and ventricular remodeling, late tricuspid valve regurgitation and pulmonary hypertension (PH) in patients after mitral valve replacement (MVR). Methods: A total of 46 patients (mean age 66 ± 9.3 years) with mitral valve diseases and undergoing isolated MVR was enrolled in the study. The mitral valve effective orifice area (EOA) was determined using the continuity equation and indexed for the patient’s body surface area (EOAi). PPM was defined as EOAi ≤1.2 cm2/m2. PH was defined as a systolic pulmonary artery pressure (sPAP) >40 mmH…

Heart Valve Prosthesis ImplantationMaleProsthesis-Patient MismatchHypertension PulmonaryHemodynamicsMitral Valve InsufficiencySettore MED/23 - Chirurgia CardiacaMitral Valve ReplacementMiddle AgedTricuspid Valve InsufficiencyTreatment OutcomeRisk FactorsHeart Valve ProsthesisProsthesis FittingHumansSettore MED/05 - Patologia ClinicaFemaleEmergenciesHospitals TeachingProsthesis-Patient Mismatch; Mitral Valve ReplacementAgedRetrospective Studies
researchProduct

Preoperative evaluation before MitraClip®: present and future perspective.

2014

ABSTRACT  Mitral regurgitation (MR) is the second most common heart valve disease worldwide. Currently, the management of MR is based on medical therapy (including biventricular pacing), surgery (mitral valve replacement or repair) and percutaneous therapy. However, in spite of guideline recommendations, 50% of individuals assessed in the Euro Heart Survey were not referred to surgical intervention due to comorbidities or real or perceived high risks for cardiac surgery; thus, in recent years, the focus of research has shifted to the development of percutaneous approaches to treat severe MR in order to restore valve function in a minimally invasive fashion. Among these techniques, the perc…

Heart Valve Prosthesis ImplantationMitral regurgitationmedicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentMitraClipPatient SelectionMitral valve replacementMitral Valve InsufficiencyGuidelineSurgeryCardiac surgerymedicine.anatomical_structureHeart Valve ProsthesisPreoperative CaremedicineMolecular MedicineHumansMitral ValveHeart valveCardiology and Cardiovascular MedicinebusinessPercutaneous Mitral Valve Repair
researchProduct

SIMPLE, SAFE AND EASY TECHNIQUE TO ENSURE THE CORRECT LENGTH OF ARTIFICIAL CHORDAE IN MITRAL VALVE REPAIR.

2007

Replacement of diseased chordae with Gore-Tex sutures (W. L. Gore & Assoc, Flagstaff, AZ) in patients with degenerative mitral valve insufficiency has become a standard technique used by surgeons in mitral valve repair with good long-term results. Nevertheless, determining the correct length of the artificial chordae has remained problematic. Although various procedures have been previously published, in this article we describe our approach used to achieve an accurate chordal height adjustment.

Heart Valve Prosthesis ImplantationPulmonary and Respiratory MedicineMitral valve repairmedicine.medical_specialtyVALVE REPAIR.business.industrymedicine.medical_treatmentHeart Valve DiseasesStandard techniquemedicine.anatomical_structureMitral valvemedicineChordae TendineaeHumansMitral ValveSurgeryIn patientArtificial OrgansRadiologyChordae tendineaeCardiology and Cardiovascular MedicinebusinessMitral valve surgery
researchProduct

Transgastric imaging-The key to successful periprocedural TEE guiding for edge-to-edge repair of the tricuspid valve.

2021

Intraprocedural transesophageal echocardiography (TEE) guidance plays an essential role in transcatheter repair therapy of the tricuspid valve (TV). So far, several different imaging concepts are in use. We propose an imaging protocol that fully addresses the morphological complexity of the TV and further offers efficacious workarounds for the frequently occurring restrictions of TV imaging in edge-to-edge repair of the TV. As a tertiary referral center with a large experience of more than 250 cases of transcatheter edge-to-edge repair (TEER) of the TV performed at the Heart Valve Center in Mainz/Germany, we have constantly adapted our peri-interventional echocardiographic approach to accom…

Heart Valve Prosthesis Implantationmedicine.medical_specialtyCardiac CatheterizationTricuspid valvebusiness.industryInterventional imagingTricuspid Valve Insufficiencymedicine.anatomical_structureEchocardiographymedicineKey (cryptography)Referral centerHumansRadiology Nuclear Medicine and imagingRadiologyEnhanced Data Rates for GSM EvolutionHeart valveTricuspid ValveCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealEchocardiography (Mount Kisco, N.Y.)REFERENCES
researchProduct

Cross-clamping a porcelain aorta: an alternative technique for high-risk patients

2018

Background Aortic cross-clamping in patients with porcelain aorta is associated with high mortality and morbidity rates. The aim is to establish a new approach to improve the outcome in this high-risk population. Methods Between September 2007 and November 2012, 42 patients with an aortic (N.=33; 81.3±6.4 years) or mitral valve disease (N.=9; 80.3±5.7) combined with a porcelain aorta underwent aortic (AVR) or mitral valve replacement (MVR). After arterial cannulation via distal aortic arch or femoral artery, longitudinal aortotomy under total cardiopulmonary bypass (CPB) was performed. The aorta was slowly clamped, thus mobilized atherosclerotic material could leave the aorta through the op…

MaleAortic archmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOperative TimePopulationAortic DiseasesHeart Valve Diseases030204 cardiovascular system & hematologylaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk Factorslawmedicine.arteryInternal medicineMitral valveAscending aortaCardiopulmonary bypassHumansMedicineVascular CalcificationeducationStrokeAgedRetrospective StudiesAged 80 and overHeart Valve Prosthesis Implantationeducation.field_of_studyAortaCardiopulmonary Bypassbusiness.industryMitral valve replacementGeneral Medicinemedicine.diseaseConstrictionTreatment Outcomemedicine.anatomical_structure030228 respiratory systemAortic Valvecardiovascular systemCardiologyMitral ValveFemaleSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Cardiovascular Surgery
researchProduct

Functional annulus remodelling using a prosthetic ring in tricuspid aortic valve repair: mid-term results

2013

OBJECTIVES: The functional aortic valve annulus (FAVA) is a complex unit with proximal (aorto-ventricular junction) and distal (sinotubular junction) components. The aim of our study was to evaluate the impact of the total FAVA remodelling, using a prosthetic ring, on mid-term clinical and echocardiographic-RESULTS:-after aortic valve repair. METHODS: Since February 2003, 250 patients with tricuspid aortic valve insufficiency (AI) underwent aortic valve repair. FAVA dilatation was treated by prosthetic ring in 52 patients, by isolated subcommissural plasty in 62, by subcommissural plasty plus ascending aortic replacement in 57 and by David's reimplantation procedure in 79. Survival rate and…

MaleAortic valveTime Factorsmedicine.medical_treatmentKaplan-Meier EstimateAortic valve repairRisk FactorsRecurrenceAortic Valve AnnulusAortic valveHospital MortalityUltrasonographyAged 80 and overHeart Valve Prosthesis ImplantationAnnulus (mycology)Sinotubular JunctionMiddle AgedCardiac Valve AnnuloplastyTreatment Outcomemedicine.anatomical_structureEchocardiographyHeart Valve ProsthesisReplantationReplantationcardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicineHumanAdultHeart Defects CongenitalPulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorAortic Valve InsufficiencyProsthesis DesignCardiac Valve AnnuloplastyDisease-Free SurvivalRisk analysiInternal medicinemedicineHumansSurvival rateStatisticAgedbusiness.industryPatient SelectionRisk FactorSettore MED/23 - Chirurgia CardiacaOriginal ArticlesSurgeryHeart Valve ProsthesiSurgerybusinessRepairInteractive CardioVascular and Thoracic Surgery
researchProduct

Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit …

2003

SummaryThe aim of the present study was to investigate the efficacy of three different parenterally administered anticoagulants for the prevention of thrombus formation on artificial heart valves in an experimental rabbit model.Unfractionated heparin was administered intravenously in group I (n = 10), Enoxaparin subcutaneously in group II (n = 10), fondaparinux intravenously in group III (n = 10), and no medication was administered to group IV (n = 9). Leaflets from Sulzer Carbomedics bileaflet mechanical heart valves were placed in a flow chamber. The flow chamber was filled with blood in a continuous circulation between the carotid artery and the jugular vein.In group IV the flow chamber …

MaleArtificial heart valvemedicine.drug_classmedicine.disease_causeFondaparinuxPolysaccharidesmedicineAnimalsHeart valveEnoxaparinThrombusHeparinbusiness.industryAnticoagulantAnticoagulantsThrombosisHematologyHeparinmedicine.diseaseFondaparinux SodiumMicroscopy Electronmedicine.anatomical_structureFondaparinuxHeart Valve ProsthesisAnesthesiaBlood Coagulation TestsRabbitsbusinessEnoxaparin sodiummedicine.drugThrombosis and Haemostasis
researchProduct

Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.

2021

Background: Isolated atrial fibrillation can cause mitral regurgitation (MR) in patients with normal left ventricular systolic function and no organic disease of the mitral valve. Little information is available regarding outcomes of Mitraclip in patients with atrial functional mitral regurgitation (AFMR). We aimed to evaluate 12-month clinical and echocardiographic outcomes of transcatheter mitral valve repair (TMVR) with MitraClip in patients with AFMR compared to those with ventricular functional or degenerative/mixed MR. Methods: Registry-based analysis of all consecutive patients who underwent TMVR and were included in the Spanish Registry of Mitraclip. Changes in MR and NYHA functiona…

MaleAtrial mitral regurgitation Functional mitral regurgitation MitraClipmedicine.medical_specialtyCardiac CatheterizationOrganic diseaseInternal medicineMitral valvemedicineMitraClipHumansHeart Atriacardiovascular diseasesAtrial mitral regurgitationFunctional mitral regurgitationAgedAged 80 and overHeart Valve Prosthesis ImplantationMitral regurgitationbusiness.industryMitraClipMitral Valve InsufficiencyAtrial fibrillationMiddle Agedmedicine.diseasemedicine.anatomical_structureTreatment OutcomeFunctional mitral regurgitationEchocardiographyHeart failureCardiologycardiovascular systemMitral ValveTranscatheter mitral valve repairFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct